The regulator's decision came after the company paused the study in September to review safety data following the deaths of ...

Residents of New Town's Shrachi Greenwood Nest highrise report outbreaks of typhoid and hepatitis A due to poor water quality ...

The European Medicines Agency recommended the antihemorrhagic drug eltrombopag to treat forms of thrombocytopenia and ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

Earlier this month, Kezar Life Sciences announced that the mid-stage test of zetomipzomib in lupus nephritis had been placed ...

In 2020, an estimated 54 million adults in the U.S. were living with chronic pain. Over 25 percent of them were treating ...

Medically reviewed by Jay N. Yepuri, MDMedically reviewed by Jay N. Yepuri, MD Liver fibrosis is scarring of the liver. It has many causes, including alcohol-induced damage, infections, and diseases ...

Kezar (KZR) is discontinuing development of its drug zetomipzomib for the treatment of lupus nephritis so it can focus on ...

By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...

Liver cancer is the sixth-leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

PursueCare, a leader in virtual addiction treatment, today announced the rollout of RESET ® and RESET-O ® , the only FDA-authorized prescription digital therapeutics (PDTs) for substance use disorder ...